Aeterna Zentaris Inc at JMP Securities Life Sciences Conference Transcript

Jun 15, 2022 / 04:30PM GMT
Klaus Paulini - Aeterna Zentaris Inc. - President & CEO

Okay. So I'd like to start with thanking the organizers for the opportunity to present today. And I also like to thank the audience for taking the time to watch our presentation and share our excitement and enthusiasm.

My name is Dr. Klaus Paulini. I am President and Chief Executive of Aeterna Zentaris Inc., as well as Managing Director of the wholly owned German subsidiary, Aeterna Zentaris GmbH, based in Frankfurt, where actually operations are based.

Today, I will be making forward-looking statements. Please be aware of this and also regularly check our filings and news or our postings on our social media channels.

Our investment highlights are diversified portfolio focused on areas of significant unmet medical need. We are executing a strategy to deliver multiple development and regulatory milestones. We are leveraging a network of large pharmaceutical but also university partners and collaborators. And important these days, all that is based on a strong national position with a runway expected to fund operations

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot